Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Vascor was a medical device company specializing in the development of advanced circulatory support systems. The company focused on creating a totally implantable ventricular assist device (VAD) to treat patients suffering from end-stage congestive heart failure. Its technology was designed to be a long-term solution for cardiac support, either as a bridge to transplantation or as destination therapy. Based in Pittsburgh, Pennsylvania, Vascor collaborated closely with academic institutions like Penn State University on its mechanical heart programs. In 2002, the company was acquired by Thoratec Corporation, a leader in the VAD market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Vascor.